Quick Answer
Aptevo Therapeutics Inc. reported Common Stock Shares Outstanding of 997,830 shares for the year ending 2025.
- Aptevo Therapeutics Inc. showed an increase of +24,531.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Aptevo Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: 20.25 million shares | Q1 2017: 21.22 million shares | Q2 2017: 21.31 million shares | Q3 2017: 21.43 million shares | Q1 2018: 22.44 million shares | Q2 2018: 22.67 million shares | Q3 2018: 22.68 million shares | Q1 2019: 45.09 million shares | Q2 2019: 45.10 million shares | Q3 2019: 45.28 million shares | Q1 2020: 3.23 million shares | Q2 2020: 3.23 million shares | Q3 2020: 3.23 million shares | Q1 2021: 4.45 million shares | Q2 2021: 4.88 million shares | Q3 2021: 4.90 million shares | Q1 2022: 5.01 million shares | Q2 2022: 5.09 million shares | Q3 2022: 5.09 million shares | Q1 2023: 7.24 million shares | Q2 2023: 7.54 million shares | Q3 2023: 14.47 million shares | Q1 2024: 673,430 shares | Q2 2024: 4.08 million shares | Q3 2024: 17.05 million shares | Q1 2025: 1.46 million shares | Q2 2025: 3.22 million shares | Q3 2025: 13.81 million shares.
- Historical annual values: Fiscal year 2025: 997,830 shares | Fiscal year 2024: 4,051 shares | Fiscal year 2023: 11,958 shares | Fiscal year 2022: 6.47 million shares | Fiscal year 2021: 4.90 million shares | Fiscal year 2020: 4.41 million shares | Fiscal year 2019: 3.23 million shares | Fiscal year 2018: 22.81 million shares | Fiscal year 2017: 21.61 million shares | Fiscal year 2016: 20.27 million shares | Fiscal year 2015: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: